ProQR Therapeutics N.V.（PRQR）重大事項與業績發布
| 申報日 | 表別 | 事項 | 原文 |
|---|---|---|---|
| 2026-08-13 | 6-K | FORM 6-K | SEC |
| 2026-08-13 | 6-K | — | SEC |
| 2026-06-26 | 6-K | FORM 6-K | SEC |
| 2026-06-25 | 6-K | FORM 6-K | SEC |
| 2026-06-02 | 6-K | FORM 6-K | SEC |
| 2026-05-12 | 6-K | FORM 6-K | SEC |
| 2026-05-12 | 6-K | — | SEC |
| 2026-05-04 | 6-K | FORM 6-K | SEC |
| 2026-04-30 | 6-K | FORM 6-K | SEC |
| 2026-04-08 | 6-K | FORM 6-K | SEC |
| 2026-04-08 | 6-K | FORM 6-K | SEC |
| 2026-03-25 | 6-K | FORM 6-K | SEC |
| 2026-03-12 | 6-K | FORM 6-K | SEC |
| 2026-02-09 | 6-K | FORM 6-K | SEC |
| 2026-01-08 | 6-K | FORM 6-K | SEC |
| 2025-11-06 | 6-K | — | SEC |
| 2025-11-03 | 6-K | FORM 6-K | SEC |
| 2025-10-20 | 6-K | FORM 6-K | SEC |
| 2025-08-07 | 6-K | — | SEC |
| 2025-06-26 | 6-K | FORM 6-K | SEC |
| 2025-06-03 | 6-K | FORM 6-K | SEC |
| 2025-05-08 | 6-K | — | SEC |
| 2025-05-01 | 6-K | FORM 6-K | SEC |
| 2025-04-14 | 6-K | FORM 6-K | SEC |
| 2025-03-13 | 6-K | FORM 6-K | SEC |
| 2024-12-11 | 6-K | FORM 6-K | SEC |
| 2024-12-11 | 6-K | FORM 6-K | SEC |
| 2024-12-10 | 6-K | FORM 6-K | SEC |
| 2024-12-05 | 6-K | FORM 6-K | SEC |
| 2024-11-07 | 6-K | — | SEC |
| 2024-10-25 | 6-K | FORM 6-K | SEC |
| 2024-08-08 | 6-K | — | SEC |
| 2024-05-22 | 6-K | FORM 6-K | SEC |
| 2024-05-09 | 6-K | — | SEC |
| 2024-05-08 | 6-K | FORM 6-K | SEC |
| 2024-04-23 | 6-K | FORM 6-K | SEC |
| 2024-04-19 | 6-K | FORM 6-K | SEC |
| 2024-03-13 | 6-K | FORM 6-K | SEC |
| 2024-02-15 | 6-K | FORM 6-K | SEC |
| 2024-01-19 | 6-K | FORM 6-K | SEC |
| 2024-01-05 | 6-K | FORM 6-K | SEC |
資料來自 SEC EDGAR 的 8-K／6-K 申報。8-K 是美國國內發行人的重大事項揭露（Item 2.02 為業績發布）；6-K 是外國發行人（含 ADR）的對應形式。本站僅整理連結，原文一律在 SEC 網站。